trial

High Frequency Repetitive Transcranial Magnetic Stimulation (rTMS) in Schizophrenia : a Randomized Controlled Study

NCTId NCT01022489
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 2, Phase 3 · Completed
Enrollment 72 (actual)
Sponsored by University Hospital, Caen
Primary completion 2015-02
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 2, Phase 3
Status
Completed
Enrollment
72 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Triple
Start
2009-08
Primary completion
2015-02
Eligibility
ALL · 16 Years · 65 Years

Interventions & indications

Drugs
Transcranial magnetic stimulation: rTMS

Sponsors

University Hospital, CaenLead Sponsor

Investigators

1
Sonia Dollfus, MD, PhDPrincipal Investigator

Sites

1 total
Caen, France

Linked catalysts

1
High Frequency Repetitive Transcranial Magnetic Stimulation (rTMS) in Schizophre — primary completion2015-02

Facts & assertions

4 sourced
Enrollment
72
Phase
PHASE2,PHASE3
Primary Completion Date
2015-02
Status
COMPLETED
relationships
The graph out of here
drug
Transcranial magnetic stimulation: rTMS
drug
lead_sponsor
University Hospital, Caen
company
indication
Hallucinations
indication
Schizophrenia
indication
Auditory Hallucinations in Patients With Schizophrenic Disorders
indication
investigator
Sonia Dollfus, MD, PhD
person